3 ms·

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

• brink 3y ago
  $2mil per treatment. Most sickle cell sufferers live in Africa. They won't be able to afford that. I understand that fighting death is expensive, but I really hope that cost comes down.